Phase II evaluation of liposomal doxorubicin (Doxil) in recurrent or advanced leiomyosarcoma of the uterus: a Gynecologic Oncology Group study (Q45274588)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase II evaluation of liposomal doxorubicin (Doxil) in recurrent or advanced leiomyosarcoma of the uterus: a Gynecologic Oncology Group study |
scientific article |
Statements
1 reference
Phase II evaluation of liposomal doxorubicin (Doxil) in recurrent or advanced leiomyosarcoma of the uterus: a Gynecologic Oncology Group study (English)
1 reference
Gregory Sutton
1 reference
John Blessing
1 reference
Parviz Hanjani
1 reference
Paul Kramer
1 reference
Gynecologic Oncology Group
1 reference
1 March 2005
1 reference
1 reference
96
1 reference
3
1 reference
749-752
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference